Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
Longeveron Inc. announced the granting of a Chinese patent covering potency assay methods for evaluating human mesenchymal stem cells (MSCs) derived from various tissues. This patent strengthens Longeveron's international portfolio, protecting its cell-based therapies, including its lead investigational product laromestrocel (Lomecel-B), which is i…
Psyence Biomedical Ltd. has expanded its Australian clinical site network from three to five sites, including Ramsay Health Care and NeuroCentrix, to support its ongoing Phase IIb clinical trial of natural psilocybin (NPX-5) for treating Adjustment Disorder in cancer patients receiving palliative care. This strategic move aims to enhance patient re…
FinWise Bancorp has appointed Jim Noone as CEO effective April 6, 2026, following a multi-year succession plan. The former CEO, Kent Landvatter, will transition to Executive Chairman to maintain strategic continuity. The leadership change maintains the company’s strategic direction and priorities, emphasizing stability and ongoing execution of its …
Garrett Motion Inc. introduces a new portfolio of oil-free centrifugal compressors designed for data centers, battery energy storage systems, and industrial/commercial cooling markets. These compressors offer enhanced energy efficiency, reduced maintenance, and accommodate ultra-low-GWP refrigerants, positioning Garrett as a leader in next-generati…
Telix Pharmaceuticals Limited announces the appointment of two distinguished Non-Executive Directors, Maria Rivas, MD, and William Jellison, effective May 2026, to enhance the Board's expertise in US public company governance, clinical development, and financial oversight. This strategic expansion supports Telix's evolution as a dual-listed global …
Toll Brothers, a leading U.S. luxury home builder, announced the grand opening of model homes at its Quilici - Palovista Collection in Reno, Nevada. The community offers modern, spacious single-family homes with luxury features and resort-style amenities, catering to diverse buyer segments. This opening strengthens Toll Brothers’ market foothold in…
SPX Technologies, Inc., a diversified global supplier specializing in engineered products for HVAC and detection markets, announced it will report its first quarter fiscal 2026 financial results on April 30, 2026, after U.S. markets close. The company will host a webcasted conference call to discuss the results and business outlook.
Devon Energy Corporation, a leading U.S. oil and gas producer, announced it will release its first-quarter 2026 financial results on May 5, 2026, after market close, followed by a conference call with analysts and investors on May 6.
Daktronics has been chosen by Los Angeles World Airports to provide a comprehensive upgrade to digital displays at LAX's Tom Bradley International Terminal. The project features over 30 integrated LED displays covering more than 15,000 square feet, enhancing traveler experience with cutting-edge visual technology. Installation will continue through…
First Northwest Bancorp, a Nasdaq-listed financial holding company and parent of First Fed Bank, announced the appointment of Jennifer Gribble as Chief People Officer, effective March 31, 2026. Gribble, an experienced HR leader, will lead talent acquisition, engagement, and organizational transformation initiatives to support the bank's modernizati…
Yimutian Inc., a Chinese agricultural digital service company listed on Nasdaq under ticker YMT, received a Nasdaq notification indicating non-compliance with the minimum $1.00 bid price requirement. The company has 180 days to regain compliance, or it risks delisting from Nasdaq. Yimutian is evaluating options including adjusting ADS to ordinary s…
AtaiBeckley Inc. announced positive Phase 2a clinical trial results showing that a single intranasal dose of BPL-003 achieved rapid (Day 2) and durable antidepressant responses in treatment-resistant depression patients who were also on stable SSRI therapy. The drug, which holds FDA Breakthrough Therapy Designation, was well tolerated with fast pat…
Eagle Bancorp, Inc., a Nasdaq-listed community bank holding company based in Bethesda, Maryland, announced its upcoming Q1 2026 earnings call. The company will release its financial results after market close on April 22, 2026, with a teleconference involving the CEO and CFO scheduled the next morning. The event will be accessible via telephone and…
Nurix Therapeutics reported Q1 2026 financial results, highlighting progress in its clinical development programs including enrollment in Phase 2 and plans for a Phase 3 trial of bexobrutideg for relapsed/refractory chronic lymphocytic leukemia (CLL). The company is also advancing its immunology pipeline and partnered programs with Gilead, Sanofi, …
Ascendis Pharma announced that it will directly list its ordinary shares on Nasdaq starting April 20, 2026, exchanging all existing American Depositary Shares (ADSs) for ordinary shares at a one-for-one ratio. This move aims to simplify the company's listing structure, potentially increase institutional ownership, improve liquidity, and facilitate …
KANZHUN LIMITED, operating as BOSS Zhipin, announced ongoing share repurchases totaling nearly RMB721 million so far in 2026, including a recent purchase of approximately RMB27.3 million for 603,724 shares. The program highlights the company's dedication to enhancing shareholder returns.
Parsons Corporation announced the unification of its aviation capabilities into a single North American Aviation organization. This strategic move aims to enhance delivery speed, scale, and cross-selling opportunities across global aviation markets, leveraging its extensive experience in both federal and commercial aviation sectors. The consolidati…
Akamai's latest State of the Internet report reveals a 300% increase in AI bot traffic in 2025, heavily targeting the publishing sector which now faces reduced referral traffic and revenue losses from traditional search engines due to AI-driven content retrieval. The study underscores increased threats from AI training crawlers and fetchers and off…
Endeavour Silver Corp. announced Q1 2026 production results, delivering 1,875,375 oz of silver, 11,740 oz of gold, and 3.3 million silver equivalent ounces boosted by mine expansions and improved recoveries across key sites including Terronera, Guanaceví, and Kolpa. Despite some weather-related and operational challenges, the company achieved signi…
Reliance, Inc., a leading North American metals service center company, will release its first quarter 2026 financial results on April 22, 2026, followed by a conference call on April 23 to discuss performance and outlook.
Brookfield Asset Management Ltd. announced it will host a conference call and webcast on May 8, 2026, to discuss its first quarter 2026 results. The company will release earnings prior to the call, continuing its focus on managing a diverse portfolio of alternative assets including infrastructure, energy, private equity, real estate, and credit.
Barrick Mining Corporation welcomed the Ontario Court of Appeal's dismissal of an appeal regarding human rights abuse allegations linked to its North Mara gold mine in Tanzania. The court upheld a previous ruling that the case should be adjudicated in Tanzania rather than Ontario. Barrick emphasized its zero tolerance policy on human rights violati…
FactSet announced the appointment of Joshua B. Warren as Chief Financial Officer effective April 13, 2026, replacing Helen Shan. Warren brings significant experience in asset management, fintech, and capital markets leadership. The transition is part of FactSet's ongoing strategic evolution, with the company emphasizing continuity and growth in dat…
iBio, Inc. announced regulatory clearance from Australia's Therapeutic Goods Administration and ethics approval to begin a Phase 1 clinical trial of IBIO-600, designed to preserve muscle and improve body composition in overweight and obese adults. This milestone transitions iBio into a clinical-stage company with dosing expected to begin in Q2 2026…
Climb Bio, a clinical-stage biotech company focused on immune-mediated diseases, announced an R&D Spotlight webcast on May 5, 2026, highlighting their budoprutug program, an anti-CD19 monoclonal antibody in clinical trials for diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. The webcast wil…
